| |
Groups
|
|---|
|
V(n = 122)
|
M(n = 49)
|
B(n = 33)
|
MIX(n = 67)
|
N(n = 229)
|
P
|
|---|
|
Male sex (%)
|
74(60.7)
|
26(53.1)
|
25(75.8)
|
45(67.2)
|
120(52.4)
|
>0.05
|
|
Age (years)
|
43(18–94)
|
32(18–75)
|
48(18–84)
|
33(18–80)
|
47(18–86)
|
<0.05
|
|
18-44
|
63(51.6)
|
38(77.6)
|
14(42.4)
|
47(70.1)
|
110(48.0)
|
>0.05
|
|
45-59
|
25(20.5)
|
6(12.2)
|
11(33.3)
|
6(9.0)
|
46(20.0)
|
>0.05
|
|
≥60
|
34(27.9)
|
5(10.2)
|
8(24.2)
|
14(20.9)
|
73(31.9)
|
>0.05
|
|
Smoking (%)
|
30(24.6)
|
10(20.4)
|
13(39.4)
|
13(19.4)
|
56(24.5)
|
>0.05
|
|
Coexisting disease (%)
|
17(13.9)
|
5(10.2)
|
4(12.1)
|
5(7.5)
|
47(20.5)
|
>0.05
|
|
Tumor (%)
|
3(2.5)
|
1(2.0)
|
0(0.0)
|
0(0.0)
|
3(1.3)
|
>0.05
|
|
Coronary heart disease (%)
|
7(5.7)
|
3(6.1)
|
3(9.1)
|
2(3.0)
|
20(8.7)
|
>0.05
|
|
Cardiac insufficiency (%)
|
2(1.6)
|
0(0.0)
|
0(0.0)
|
0(0.0)
|
5(2.2)
|
>0.05
|
|
Cerebrovascular disease (%)
|
5(4.1)
|
1(2.0)
|
2(6.1)
|
2(3.0)
|
11(4.8)
|
>0.05
|
|
Chronic nephropathy (%)
|
1(0.8)
|
1(2.0)
|
0(0.0)
|
0(0.0)
|
6(2.6)
|
>0.05
|
|
Chronic hepatopathy (%)
|
1(0.8)
|
0(0.0)
|
0(0.0)
|
0(0.0)
|
3(1.3)
|
>0.05
|
|
Diabetes mellitus (%)
|
4(3.2)
|
2(4.1)
|
1(3.0)
|
2(3.0)
|
21(9.2)
|
>0.05
|
|
CAP hospitalization within 1year (%)
|
0(0.0)
|
0(0.0)
|
0(0.0)
|
0(0.0)
|
2(0.9)
|
>0.05
|
|
COPD* (%)
|
4(3.2)
|
0(0.0)
|
0(0.0)
|
1(1.5)
|
3(1.3)
|
>0.05
|
|
Autoimmune disease (%)
|
1(0.8)
|
0(0.0)
|
0(0.0)
|
0(0.0)
|
0(0.0)
|
>0.05
|
|
Antibiotic pretreatment (%)
|
75(61.5)
|
35(71.4)
|
24(72.7)
|
42(62.7)
|
147(64.1)
|
>0.05
|
- Notes: V: single viral infection; M: single mycoplasma pneumoniae infection; B: single bacterial infection; MIX: mixed infections; N: no pathogen detected.*COPD, chronic obstructive pulmonary disease.
